Rende Gu Selected Research

ebselen

1/2021	Ebselen attenuates tobramycin-induced ototoxicity in mice.
1/2020	A Novel Mouse Model of Aminoglycoside-Induced Hyperacusis and Tinnitus.
4/2007	Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase.
6/2005	Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity.
3/2005	Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
2/2004	Ebselen-mediated protection from single and repeated noise exposure in rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rende Gu Research Topics

Disease

3	Hearing Loss (Hearing Impairment) 01/2021 - 03/2005
3	Ototoxicity 01/2021 - 03/2005
3	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2020
2	Infections 01/2021 - 01/2020
2	Tinnitus 01/2021 - 01/2020
2	Hyperacusis (Phonophobia) 01/2021 - 01/2020
2	Noise-Induced Hearing Loss (Acoustic Trauma) 04/2007 - 02/2004
2	Neoplasms (Cancer) 06/2005 - 03/2005
1	Reinfection 01/2021
1	Central Auditory Diseases 01/2020
1	Labyrinth Diseases 03/2013
1	Ovarian Neoplasms (Ovarian Cancer) 06/2005
1	Deafness (Deaf Mutism) 03/2005

Drug/Important Bio-Agent (IBA)

6	ebselenIBA 01/2021 - 02/2004
2	AminoglycosidesIBA 01/2021 - 01/2020
2	Tobramycin (Nebcin)FDA LinkGeneric 01/2021 - 01/2021
2	Amikacin (A.M.K)FDA LinkGeneric 01/2021 - 01/2020
2	Glutathione PeroxidaseIBA 04/2007 - 02/2004
2	Allopurinol (Remid)FDA LinkGeneric 06/2005 - 03/2005
2	Cisplatin (Platino)FDA LinkGeneric 06/2005 - 03/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Investigational DrugsIBA 01/2020
1	AntioxidantsIBA 01/2020
1	ChitosanIBA 03/2013
1	GlycerophosphatesIBA 03/2013
1	HydrogelsIBA 03/2013
1	chitosanaseIBA 03/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2005

Therapy/Procedure

1	Therapeutics 03/2013
1	Oral Administration 03/2005